Influenza Diagnostics Market By Test Type (Rapid Influenza Diagnostic Test [RIDT], Reverse Transcription Polymerase Chain Reaction[RT-PCR], Cell Culture, Others - Immunofluorescence, Serology), By End Use (Hospitals, Laboratories, POCT), And Segment Forecasts To 2024

Published: Sep, 2016 | Pages: 77 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The influenza diagnostics market is expected to reach USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc. Influenza, or "the flu," is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on public health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC's seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season.

Rapid Influenza Diagnostic Tests (RIDTs) accounted for the largest share in 2015. RIDTs are tests that deliver accurate results in approximately 15 minutes. This factor deems them efficient, which has resulted in the lucrative growth of this segment with the fastest CAGR. Reverse transcription polymerase chain reaction (RT-PCR) holds the second highest market share following RIDTs, and this can be attributed to the fact that it provides detailed analytical results, sharper turnaround times, and high throughput.

Hospitals held the highest market share in 2015, but Point-of-Care Testing (POCT) is anticipated to overtake and lead the market in the coming future, owing to the increasing usage of POCT because of its ease of use and short turnaround times.

North America dominates the market, due to a high focus of the government and healthcare bodies to control influenza.

Further Key Findings From the Study Suggest:

North America is anticipated to dominate the global influenza diagnostics market. The high adoption rates of in vitro diagnostics and presence of technologically advanced medical devices is expected to drive growth in the region.

The Asia Pacific region is anticipated to be the fastest growing region in the study period. This growth is attributed to factors such as increasing initiatives by the countries to counter the incidence of the disease. For instance, CDC reached a cooperative agreement with South-East Asian Region to fund non research-related bilateral influenza as a measure to respond to avian, seasonal, and pandemic influenza.

The RIDT segment is expected to grow at a significant rate compared to others and accounts for the largest share in 2015.

This market comprises several local as well as global players. Some of the major players of this vertical include Becton, Dickinson and Company, Roche Diagnostics, Alere, Quidel Corporation, and Thermo Fisher Scientific.

 Table of Contents

Chapter 1 Research Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Market Snapshot

Chapter 4 Market Variables, Trends& Scope
                    4.1 Market Segmentation&Scope
                          4.1.1 Market driver analysis
                                4.1.1.1 Rising base of geriatric population (aged 65 years or older) 
                                4.1.1.2 Increasing prevalence of chronic diseases such as respiratory, heart and blood disorders
                                4.1.1.3 Growing government initiatives to counter influenza
                                4.1.1.4 Emergence of technologically advanced influenza diagnostics tests
                          4.1.2 Market restraint analysis
                                4.1.2.1 Product safety and high cost of development
                    4.2 Key Opportunities Prioritized
                    4.3 Influenza Diagnostics Market- SWOT Analysis, by Factor (Political & Legal, Economic & Technological)
                    4.4 Industry Analysis - Porter's Five Forces Analysis
                    4.5 Influenza Diagnostics Market: Market Share Analysis, 2015

Chapter 5 Market Categorization 1: Test Type Estimates & Trend Analysis
                    5.1 Influenza Diagnostics Market: Technology Movement Analysis
                    5.2 RIDT
                          5.2.1 Market estimates and forecasts, 2013 - 2024 (USD Million)
                    5.3 RT-PCR
                          5.3.1 Market estimates and forecasts, 2013 - 2024 (USD Million)
                    5.4 Cell Culture
                          5.4.1 Market estimates and forecasts, 2013 - 2024 (USD Million)
                    5.5 Others
                          5.5.1 Market estimates and forecasts, 2013 - 2024 (USD Million)

Chapter 6 Market Categorization 2: End-use Estimates & Trend Analysis
                    6.1 Influenza Diagnostics Devices Market: Technology Movement Analysis
                    6.2 Hospitals
                          6.2.1 Market estimates and forecasts, 2013 - 2024 (USD Million)
                    6.3 POCT
                          6.3.1 Market estimates and forecasts, 2013 - 2024 (USD Million)
                    6.4 Laboratories
                          6.4.1 Market estimates and forecasts, 2013 - 2024 (USD Million)

Chapter 7 Market Categorization 3: Regional Estimates & Trend Analysis, by Application and Technology
                    7.1 Influenza Diagnostics Devices Market Share by Region, 2015 & 2024
                    7.2 North America
                          7.2.1 North America influenza diagnostics market, 2013 - 2024 (USD Million)
                          7.2.2 U.S.
                                7.2.2.1 U.S. influenza diagnostics market, 2013 - 2024 (USD Million)
                          7.2.3 Canada
                                7.2.3.1 Canada influenza diagnostics market, 2013 - 2024 (USD Million)
                    7.3 Europe
                          7.3.1 Europe influenza diagnostics market, 2013 - 2024 (USD Million)
                          7.3.2 UK
                                7.3.2.1 UK influenza diagnostics market, 2013 - 2024 (USD Million)
                          7.3.3 Germany
                                7.3.3.1 Germany influenza diagnostics market, 2013 - 2024 (USD Million)
                    7.4 Asia Pacific
                          7.4.1 Asia Pacific influenza diagnostics market, 2013 - 2024 (USD Million)
                          7.4.2 China
                                7.4.2.1 China influenza diagnostics market, 2013 - 2024 (USD Million)
                          7.4.3 India
                                7.4.3.1 India influenza diagnostics market, 2013 - 2024 (USD Million)
                    7.5 Latin America
                          7.5.1 Latin America influenza diagnostics market, 2013 - 2024 (USD Million)
                          7.5.2 Brazil
                                7.5.2.1 Brazil influenza diagnostics market, 2013 - 2024 (USD Million)
                          7.5.3 Mexico
                                7.5.3.1 Mexico influenza diagnostics market, 2013 - 2024 (USD Million)
                    7.6 MEA
                          7.6.1 MEA influenza diagnostics market, 2013 - 2024 (USD Million)
                          7.6.2 South Africa
                                7.6.2.1 South Africa influenza diagnostics market, 2013 - 2024 (USD Million)
                          7.6.3 Saudi Arabia
                                7.6.3.1 Saudi Arabia influenza diagnostics market, 2013 - 2024 (USD Million)

Chapter 8 Competitive Landscape
                    8.1 Company Profiles
                          8.1.1 Becton, Dickinson and Company
                                8.1.1.1 Company overview
                                8.1.1.2 Financial performance
                                8.1.1.3 Product benchmarking
                                8.1.1.4 Strategic initiatives
                          8.1.2 Quidel Corporation
                                8.1.2.1 Company overview
                                8.1.2.2 Financial performance
                                8.1.2.3 Product benchmarking
                                8.1.2.4 Strategic initiatives
                          8.1.3 Roche
                                8.1.3.1 Company overview
                                8.1.3.2 Financial performance
                                8.1.3.3 Product benchmarking
                                8.1.3.4 Strategic initiatives
                          8.1.4 Sekisui Diagnostics, LLC
                                8.1.4.1 Company overview
                                8.1.4.2 Financial performance
                                8.1.4.3 Product benchmarking
                                8.1.4.4 Strategic initiatives
                          8.1.5 SA Scientific Ltd.
                                8.1.5.1 Company overview
                                8.1.5.2 Financial performance
                                8.1.5.3 Product benchmarking
                                8.1.5.4 Strategic initiatives
                          8.1.6 Meridian Bioscience, Inc.
                                8.1.6.1 Company overview
                                8.1.6.2 Financial performance
                                8.1.6.3 Product benchmarking
                          8.1.7 Thermo Fisher Scientific
                                8.1.7.1 Company overview
                                8.1.7.2 Financial performance
                                8.1.7.3 Product benchmarking
                          8.1.8 3M Health Care
                                8.1.8.1 Company overview
                                8.1.8.2 Financial performance
                                8.1.8.3 Product benchmarking
                                8.1.8.4 Strategic initiatives
                          8.1.9 Alere
                                8.1.9.1 Company overview
                                8.1.9.2 Financial performance
                                8.1.9.3 Product benchmarking
                                8.1.9.4 Strategic initiatives

List of Tables

TABLE 1 North America influenza diagnostics market, 2013 - 2024 (USD Million)
TABLE 2 North America influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 3 North America influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 4 U.S. influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 5 U.S. influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 6 Canada influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 7 Canada influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 8 Europeinfluenza diagnostics market, 2013 - 2024 (USD Million)
TABLE 9 Europeinfluenza diagnostics market, by test type, 2013 - 2024 (USD Million))
TABLE 10 Europeinfluenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 11 UK influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 12 UK influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 13 Germanyinfluenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 14 Germanyinfluenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 15 Asia Pacificinfluenza diagnostics market, 2013 - 2024 (USD Million)
TABLE 16 Asia Pacificinfluenza diagnostics market, by test type, 2013 - 2024 (USD Million))
TABLE 17 Asia Pacificinfluenza diagnostics market, by enduse, 2013 - 2024 (USD Million)
TABLE 18 Chinainfluenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 19 Chinainfluenza diagnostics market, by enduse, 2013 - 2024 (USD Million)
TABLE 20 Indiainfluenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 21 Indiainfluenza diagnostics market, byenduse, 2013 - 2024 (USD Million)
TABLE 22 Latin America influenza diagnostics market, 2013 - 2024 (USD Million)
TABLE 23 Latin America influenza diagnostics market, by test type, 2013 - 2024 (USD Million))
TABLE 24 Latin Americainfluenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 25 Brazil influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 26 Brazil influenza diagnostics market, by enduse, 2013 - 2024 (USD Million)
TABLE 27 Mexicoinfluenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 28 Mexicoinfluenza diagnostics market, by enduse, 2013 - 2024 (USD Million)
TABLE 29 MEAinfluenza diagnostics market, 2013 - 2024 (USD Million)
TABLE 30 MEA influenza diagnostics market, by test type 2013 - 2024 (USD Million)
TABLE 31 MEAinfluenza diagnostics market, by enduse 2013 - 2024 (USD Million)
TABLE 32 South Africa influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 33 South Africa influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 34 Saudi Arabia influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 33 Saudi Arabia influenza diagnostics market, by end use, 2013 - 2024 (USD Million)